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All organisms require an equivalent source for living. Reduced glutathione is the most abundant thiol 
containing protein in mammalian cells and organs. Glutathione was discovered by Hopkins in 1924 who 
published his findings in JBC. It is a three peptide containing glutamic acid, cystein and glycin and is 
found in reduced and oxide forms in cell. High concentration of glutathione and its high reduced/oxide 
potential makes GSH a powerful antioxidant and the first defense line against free radicals. However, 
glutathione is the most efficient tool for detoxification of xenobiotic. In several studies, the effect of GSH 
on different cell types has been investigated and so, in this study, a review of the glutathione function, 
focusing on cell proliferation and differentiation would be carried out.  
 





Glutathione (GSH) is a major source of reducing equiv-
alents in mammalian cells (Shi et al., 2000). In mammalian 
tissue and cells, glutathione is the major non-protein thiol 
agent (Mullick et al., 1986) and it is essential for the 
survival of eukaryotic, but not in prokaryotic cells (Miranada 
et al., 1996) (Figure 1). In fact, GSH plays an important 
role in cell proliferation. Nonetheless, most GSH co-
localizes with nuclear DNA when cells are proliferating 
(Pallardo et al., 2009).  
 
 
HISTORY OF GLUTATHIONE 
 
Sir Frederick Gowland Hopkins in 1924 made the discovery 
and characterization of glutathione, which is described in 
classical paper of the Journal of Biological Chemistry 
(JBC) (Figure 2). It had been recognized that, glutathione 
under-went reversible oxidation-reduction, which involved 
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glutathione disulfide (GSSG). Although, the discovery of 
glutathione certainly ranks among the major discoveries 
in biochemistry, Hopkins is unfortunately remembered for 
his error regarding the structure of glutathione, which he 
had concluded was a dipeptide of glutamic acid and 
cysteine. Moreover, the structure of glutathione was con-
troversial for several years. In 1927, Hunter and Eagles 
described a product that was isolated using the same 
procedure employed by Hopkins which had significantly 
less sulfur per mass and was possibly a tripeptide. After 
seeing a preprint version of the Hunter and Eagles paper 
provided by the editors of JBC, with permission of the 
authors, Hopkins responded that, their preparation of 
glutathione was impure and reasserted that glutathione 
was a dipeptide. In 1929, after developing a new procedure 
for preparing crystalline glutathione, Hopkins recognized 
that “Hunter and Eagles were right in doubting that the 
substance was a simple dipeptide of glutamic acid and 
cysteine. He then showed that, glutathione is indeed a 
tripeptide of glutamic acid, glycine and cysteine. 
Although, he did not determine the precise structure, he 
suggested that it was Glu-Cys-Gly (The structure of 
glutathione is, in fact, γ-L-glutamyl-L-cysteinylglycine) 
(Hopkins, 2002). 

















STRUCTURE OF GLUTATHIONE  
 
Glutathione is a small molecule made up of three amino 
acids (glycine, cysteine and glutamic acid) (Mullick et al., 
1986) (Figure 3).  
 
 
Glutathione find in two forms: 
 
1. Monomer form that is single molecule and named 
reduction glutathione (GSH). 
2. Dimmer form that two single molecule is under effect of 
disulfide bond. Dimmer form is named GSSG (Mullick et 
al 1986). 
 
GSSG is transformed under the effect of the enzyme that 
is named reductase glutathione and which produced a 
reduction glutathione. Reduction glutathione is an active 
form of glutathione, and more than 90% of the glutathione 
is in the reduction form in cells and tissue. The 
metabolism of hydroperoxides via the glutathione (GSH), 
3 GSH reductase and GSH peroxidase pathway, 
represents one of the major cellular defense mechanisms 
against oxidative stress. GSH is a tripeptide (γ-
glutamylcysteinylglycine) that cycles between its oxidized 
GSSG and its reduced GSH state of detoxify hydro-
peroxides in concert with GSH peroxidase, using the 
reducing equivalents in NADPH and GSH reductase. In 
the absence of oxidative stress, 90 to 95% of GSH is in 
its reduced state (Mullick et al., 1986) (Figure 4). 
 
 




The high density of glutathione and the reduction/ 
xidation potential made this syntax a powerful anti-
oxidant and first defense struck against the free radical in 
cells. Glutathione is a cofactor for peroxidase glutathione 
enzyme that has an important role in ventilate of 
peroxides lipid (Hayes et al., 1999; Abedelahi et al., 
2010). Dehydroascorbat reductase enzyme, with the use 
of glutathione, reduces dehydroascorbate to ascorbat. 
Glutathione impound antioxidants like vitamin E and 
carotenoids in reduction statute (Jones, 2002; J M, 1991).  
There are two kinds of anti oxidant systems: anti 
oxidants like catalase, glutathione peroxidase (GPx) and 
glutathione S-transferase (GST) and non enzymes anti 
oxidants like albumin, ascorbate, solphidrile group and 
vitamin E (Sharma and Agarwal, 1996; Aitken, 1995). 
Glutathione is one of the endogenous thiols that plays 
role in cells such as antioxidant defenses (Ahmadi 





Glutathione used cells material to remove poison from 
drugs, insecticide syntax, heavy metal and other 
xenobiotic material and neutralized them before 
repercussion with the cells component like nucleic acids 
and proteins (Chevion et al., 1982; Behroozikhah et al., 
1992; Allameh et al., 2002; Behroozikhah et  al., 1993). In  






Figure 3. The structure of glutathione. A: Stereo view of F0 - Fc electron density 





addition, the chemical response and enzyme attendance 
is also used to remove the poison activation of 
glutathione. However, the intracellular concentration of 
this tripeptide plays an important role in determining the 
sensitivity of cells to radiation and drug induced 
cytotoxicity. The glutathione syntax with xenobiotic in the 
chemical response is proximate, whereas in glutathione 
enzyme syntax, the attendance of glutathione S-
transferase enzyme is conjugated with the poison syntax 
(Hayes et al., 1999; Jones, 2002). Conjugations trans-
formed via membrane bails to the cell are deserted from 
the body to form mercaptorice acid. Nevertheless, a high 
number of poison syntax caused a decrease in 
glutathione and in the vulnerable cells versus oxidative 
shocks (Hayes et al., 1999; Behroozikhah et al., 1993; 
Pompella et al., 2003). Allameh et al. suggested that the 
glutathione system, like other systems, is incorrect in 
immature animal and mature rats in comparison with the 
immature rats that demonstrated more sensitivity to 
aphlatoxin (Behroozikhah et al., 1993). 
 
 
Regulation role  
 
Glutathionilation has an important role in the regulation 
proteins turnover and a role in outer cell proteins stability 
and custody from cystein stems against oxidation and 
regulation of many enzyme and reproduction agents 
(Pastore et al., 2003). Oxidized GSH (GSSG) has been 
assumed to be the major source of the oxidizing 
equivalents for disulfide-bond formation associated with 
protein folding, of which a lot of the proteins became 






Glutathione has a major role in the immune system 
turnover in lymphocytes activation (Droge et al., 1986). 
Different subclass lymphocyte in activation is dependent 
on different counts of glutathione. A lack or decrease of 





 cells in this statute have more activity 
(Gmunder et al., 1991). Moreover, a metabolism of some 
cytokine-like interleukin-2 is needed by glutathione. The 
relevance between glutathione and the immune system is 
not discovered completely, although in this process, the 
response is perhaps between the nuclear factor KB and 
glutathione (Mihm et al., 1995). Allameh et al. (2008, 
2007) suggested that in bedridden rats, the glutathione 
system (especially glutathione S-transferase) have an 
important role in the decrease of tort oxidative to central 
nervous system (CNS). Human T lymphocytes depleted 
GSH, using Buthionine sulphoximine (BSO) were unable 
to proliferate in response to mitogenic lectins, which 
suggested a direct relationship between the proliferative 
response and GSH availability. 






Figure 4. Glutathione substrate (in thick lines) in the GST binding site. A: Glutathone in Sj 
GST. B: Glutathione in µGST. C: S-benzyl-glutathione in α GST. D: Glutathione sulfonate 




BIOSYNTHESIS AND ANALYSIS OF GLUTATHIONE  
 
Liver is an important place for synthase, except for 
glutathione plasma. Synthesis in two responses has been 
catalyzed to γ-glutamylcysteine and glutathione synthe-
tase (Allameh et al., 1986; Mabrouk et al., 1998).  
γ- Glutamylcysteine synthesis enzyme is the most 
important cramp enzyme in glutathione synthase way. 
This enzyme is heterodimeric and it has two subunit (30 
kilo Dalton) and heavy unit (73 kilo Dalton) lights that are 
bonded to each other with disulphide bond (Griffith and 
Mulcahy, 1999). Heavy unit have catalytic activity 
enzyme, but light unit regulates enzyme Km for glutamate 
(Griffith and Mulcahy, 1999). The glutathione analysis in 
and out of the cell is accomplished by two γ-glutamyl 
transferase and dipeptidase enzyme that is found on the 
surface of the epithelial cells membrane. γ- Glutamyl 
transferase enzyme separates the basis of γ-glutamyl 
from glutathione molecule and in other stages; 
dipeptidase enzyme separates the glisil root (Lu, 2000). 
Amino acids from glutathione analysis can come back to 
the cell, and like reflexes 1 and 2, they can be used for 
synthase inner cell glutathione (Meister, 1973). It is 
important to know that, kidney, lung and intestine are 
salient consumer plasma glutathione (Lu, 2000) (Figure 5 
and 6).  
 
 
ROLE OF THE AMINO ACID FORMED GLUTATHIONE 




Cysteine is a thiol containing amino acid and a rate-
limiting precursor of glutathione. It is still unresolved as to 
whether the proliferative effect of cysteine or cystine is 
entirely mediated by a change in the intracellular 
glutathione status. In the presence of DL-buthionine-[S, 
R]-sulfoximine (BSO), in CaCO-2 cell line, a glutathione 
synthesis inhibitor that exogenously administered 
cysteine did not change the intracellular glutathione 
content, but increased the intracellular cysteine, as well 
as the cystine level. Both cysteine and cystine have 
proliferative effects in CaCO-2 cells independent of an 
increase in intracellular glutathione. Cysteine exists in 
equilibrium  between   the   reduced   and   oxidized  form  
















known as cystine. Cystine predominates in the extra-
cellular environment, while cysteine predominates in the 
intracellular environment. T lymphocytes are not able to 
take up cystine from the surrounding environment and 
convert it to cysteine. Neither GSH nor cysteine levels 
are required for T cell proliferation, but rather GSH and 
cysteine are rate limiting only in the absence of other low 
mloecular weight reduced thiols. This suggests that 
reduced thiols, but not necessarily GSH, are required for 
T cell proliferation. In addition, depletion of the intra-
cellular thiols selectively impairs IL-2 secretion without 
affecting the expression of T cell activation surface 
markers or cell viability. Inhibition of T cell proliferation by 
BSO is completely overcome by exogenous IL-2. These 
results support the hypothesis that T cell proliferation is 
dependent on thiol-mediated regulation of IL-2 secretion, 
and suggest that redox regulation of IL-2 secretion is an 
obligatory step in T cell proliferative responses. Induction 
of cyclin D1, phosphorylation of Rb, and subsequent 
facilitation of G1-to-S phase transition were involved in 
the proliferative effect of exogenous  cysteine (Noda  and  





Glycine is included in saliva in large quantities and it 
reportedly has important roles in antibacterial activities 
and the inhibition of tumor growth as a precursor of 
nucleotide synthesis in cell proliferation. Glycine 
promotes three-dimensional formations of mouse 
salivary-gland-derived progenitor cells (mSGP), which 
are negative for immature markers and positive for 
differentiation markers. In cell-cycle analysis, cell-cycle 
progression is delayed at the S-phase by glycine 
supplementation. Glycine also suppresses the 
phosphorylation of p42/p44MAPK. These results suggest 
that glycine suppresses proliferation and promotes the 
differentiation of mSGP cells, and that it has inhibitory 
effects on growth factor signaling and cell-cycle 
progression. Glycine inhibited the cell-cycle progression 







Figure 7. Cysteine chemical structure 










effects of glycine were independent of apoptosis. There-
fore, glycine regulated the cell cycle and cell proliferation 
without toxicity. The cell-cycle that is captured at the S-
phase usually indicates a delay of DNA synthesis or DNA 
repair. Glycine exerts an effect on the differentiation of 
mSGP cells at an early stage. The S-phase delay in non-
proliferating cells treated with glycine might be caused by 
a delay in DNA synthesis or a delay in the G2/M 
transition accompanying the inhibition of growth factors. 
Since glycine prevents increases in [Ca
2+
] in other types 
of white blood cells and calcium which is important in the 
activation of T lymphocytes, it was hypothesized that 
glycine would prevent T lymphocyte proliferation and be 
immunosuppressive by a mechanism involving the 
activation of a glycine-gated chloride channel (Mihm et 





Glutamic acid is one of the amino acid in glutathione that 
plays a role in proliferation and cell apoptosis. The 
significant increase in the area of p53 expression by the 
action of asparagine, lysine and glutamic acid in 
immature lymphoid tissue in the immunohistochemical 
study indicates that the decrease in cell proliferation in 
the growth zone at this period is related to the 
enhancement of apoptosis (Suzuki et al., 2006).  
 
 
GLUTATHIONE AND BRAIN 
 
The cells of the adult human brain consume <20% of  the  











oxygen utilized by the body, although the brain comprises 
only 2% of the body weight. Reactive oxygen species, 
which are produced continuously during oxidative 
metabolism, are generated at high rates within the brain. 
Therefore, the defense against the toxic effects of 
reactive oxygen species is an essential task within the 
brain. An important component of the cellular detoxi-
fication of reactive oxygen species is the antioxidant 
glutathione. This indicates the generation of a large 
quantity of ROS during oxidative phosphorylation in the 
brain. The best evidence of an altered glutathione 
metabolism, as an important factor contributing to the 
pathogenesis of a neurodegenerative disease, has been 
found in Parkinson's disease. The involvement of a 
compromised glutathione system in a neurological 
disorder is reviewed by Schulz et al. in this issue. In this 
context, insufficient mitochondrial functions are consi-
dered to play an important role, while in the presence of 
astroglial cells, neurons are protected against the ROS-
induced toxicity of various compounds and treatments. In 
coculture, neurons are protected against H2O2 toxicity 
even at a cellular ratio of 1 astroglial cell to 20 neurons. 
Neurons in culture become damaged by extracellular 
ROS which are detoxified in the presence of astroglial 
cells. GSH is important for this function, because the 
protective effect of astroglial cells is diminished when 
these cells contain low levels of GSH. For the synthesis 
of GSH, a metabolic interaction between neurons and 
astroglial cells takes place. Only the availability of 
cysteine determines the level of neuronal GSH. If 
neurons are cultured in the presence of astroglial cells, 
the GSH content of the neurons increases strongly, 
indicating that, in the presence of astroglial cells, a 
cysteine precursor is provided from the astroglial cells to 
the neurons improving neuronal GSH synthesis. The 
dipeptide CysGly, which is generated from extracellular 
GSH by the gGT reaction, is utilized efficiently in micro-
molar concentrations as a precursor for neuronal GSH. 
Inhibition of gGT prevented totally the astroglial-induced 
effect on the GSH content in neurons demonstrating that 
CysGly is most probably the GSH precursor provided by 
astroglial cells to neurons (Gutterer, 2000) (Figure 9). 










GLUTATHIONE AND LIVER 
 
To investigate the effects of the intravenous admini-
stration of the antioxidant glutathione (GSH) on reper-
fusion injury, a study was done on liver transplantation. 
Intravenous GSH treatment during liver transplantation 
prevents reperfusion injury of the liver allograft. Intra-
venous infusion of 50 μmol GSH/ (h·kg) during reper-
fusion of liver allografts resulted in a several fold increase 
of plasma GSH, whereas plasma GSSG did not exceed 
the levels of untreated controls. A comparable increase of 
plasma GSH was observed when sham-operated or 
transplanted animals were treated with 100 μmol GSH/ 
(h·kg). In contrast, a 2.5-fold higher increase of plasma 
GSSG was determined in transplanted rats. This 
difference clearly indicates that spontaneous oxidation of 
intravenously applied GSH contributes only in part to the 
increase in plasma GSSG. Oxidation of GSH by ROS 
appears as a major determinant of plasma GSSG 
formation following liver transplantation. Intravenously 
applied GSH protects liver allografts against the vascular 
oxidant stress produced by KC during reperfusion. 
However, the plasma GSH above a critical level may act 
as a “sink” for ROS produced by KC during reperfusion. 
This could be due to non-enzymatic reactions between 
GSH and various ROS which strongly depend on the 
GSH concentration (Schauer, 2004) (Figure 10). 
 
 
GLUTATHIONE AND TELOMERES 
 





which consist of telomeric DNA repeated in tandem and 
associated with several proteins. These structures play 
an important role in the stability and complete replication 
of the chromosomes. Conventional DNA polymerases 
cannot fully replicate the 3’-end of the lagging strand of 
linear molecules, and therefore telomeric sequences are 
lost in every cell division. Telomerase is an important 
enzyme that ensures the maintenance of normal telo-
mere length. This activity is high in human cancers, but 
virtually absent in normal human tissues, except germinal 
cells. Telomerase plays a key role in cellular home-
ostasis, because it maintains the length of the telomeres. 
This is especially important in germinal cells in which it is 
necessary to keep a normal telomeric length after many 
cellular divisions. Mammalian telomeres and subtelo-
meric regions are enriched in epigenetic markers that are 
characteristic of heterochromatin. As would be discussed 
later, glutathione may play a major role in the epigenetic 
control. Physiological variations in glutathione levels 
induce changes in telomerase activity that is in con-
cordance with changes in cell cycle regulatory proteins. 
The importance of glutathione regulation in telomerase 
activity has been proved in endothelial progenitor cells 
(EPC). Impairment of antioxidant defenses in EPC 
promotes oxidant mediated apoptosis and telomerase 
inactivation, giving rise to the development and/or 
progression of atherothrombosis. Telomerase is regu-
lated by the shift in glutathione redox potential within 
values, and alterations in telomerase activity are 
coordinated with changes in critical cell cycle proteins, 
particularly Id2 and E2F4 (Esteve et al., 2004). 
 
 
GLUTATHIONE AND APOPTOSIS 
 
Apoptosis is a cell death that control cells in germ 
differentiation, immune response, hormones regulation 
and homeostasis. Free radicals may be involved in 
apoptosis although this is the subject of some 
controversy. Furthermore, the source of free radicals in 
apoptotic cells is not certain. Oxidized glutathione 
(GSSG) levels in mitochondria from lactating mammary 
gland are also higher in apoptosis. There is a direct 
relationship between the mitochondrial DNA (mtDNA) 
damage and the GSSG/reduced glutathione (GSH) ratio. 
Furthermore, the entire cell’s GSH is decreased and 
GSSG is increased in both models of apoptosis. 
Glutathione oxidation precedes nuclear DNA fragmen-
tation. These signs of oxidative stress are caused, at 
least in part, by an increase in peroxide production by 
mitochondria from apoptotic cells (Toshiyuki and 
Takahito, 2009) (Figure 11, 12 and 13). 
Cytochrome c is a nuclear-encoded component of the 
mitochondrial respiratory chain that is imported as an 
apoenzyme into mitochondria, where it is converted to 
the mature form by the addition of a heme group. It 
catalyzes the electron transfer between complexes III and  












Figure 12. Mechanisms involved in GSH depletion during apoptosis.  










IV of the respiratory chain, moving within the planar 
surface of the inner mitochondrial membrane. The 
release of mature cytochrome c from mitochondria has a 
cellular response to the depletion of glutathione and the 
main intracellular antioxidant, which is independent from 
the destiny of the cells, that is, apoptosis or survival. On 
one hand, cytosolic cytochrome c was detected in cells 
where the inhibition of glutathione synthesis led to 
glutathione depletion without impairing viability or in tight 
concomitance with glutathione depletion prior to 
puromycin-induced apoptosis. A removal of the 
apoptogenic agent prior to apoptosis, after glutathione 
extrusion and cytochrome c release, led to a recovery of 
the preapoptotic cells, which took up healthy features, 
that is, it restored the normal glutathione levels and 
disappearance of cytosolic cytochrome c. On the other 
hand, in an example of apoptosis occurring without 
glutathione depletion, no translocation of cytochrome c 
from mitochondria to cytosol was detected. Unlike the 
other instances of apoptosis, in this case, caspase 3 was 
not activated, thus suggesting the following oxidant-
related apoptotic pathway: glutathione depletion, 
cytochrome C release and caspase 3 activation. Cyto-
chrome c release is not a terminal event leading cells to 
apoptosis, but rather is the consequence of a redox 
disequilibrium which, under some circumstances, may be 
associated with apoptosis. Glutathione depletion causes 
cytochrome c release even in the absence of cell 
commitment to apoptosis. Prevention of GSH extrusion 
prevents apoptosis, showing that GSH extrusion is 
necessary for the downstream events of apoptosis, 
probably via the alteration of the intracellular redox 
signaling (Ghibelli et al., 1999). The release of cyto-
chrome c occurs in all instances of glutathione depletion, 
obtained either by direct inhibition of glutathione neo-
synthesis (with buthionine sulfoximine) or indirectly, by 
eliciting apoptosis-linked GSH extrusion. Instead, no 
correlation was found between cytochrome c release and 
apoptosis, since cytochrome c can also be released in 
viable cells (when GSH is depleted), whereas cells might 
undergo apoptosis without releasing cytochrome c, when 




GLUTATHIONE, CANCER AND CHEMOTHERAPY 
RESISTANCE 
 
One of the ways for cancer therapy is the use of special 
drugs in medicine called chemotherapy. The mechanism 
for most of these drugs is apoptosis induction in cancer 
cells, although factor and different reasons for the 
success of chemotherapy are also involved. Sometimes, 
some of these reasons cause recovery improvement, 
while some others are resistance to chemotherapy and 
finally causes failure in cancer therapy. Investigations of 
scientists show that glutathione is the factor that makes 
resistance to chemotherapy and it plays a major role in 
this matter (Mohammadzadeh et al., 2003). For example, 
the role of glutathione in curing pancreatic carcinoma can 
be referred to. Analysis of the reduced glutathione shows 





comparison to cancer tissues. This result shows that after 
increasing glutathione in pancreatic carcinoma, prolife-
ration and resistance to chemotherapy in the human 
pancreatic carcinoma (AsPC-1) are increased. Thus, a 
decrease of the glutathione level may be caused by the 
development of chemotherapy in pancreatic carcinoma. 
Combination of BSO is efficient in decreasing glutathione 
level and it causes a good effect on cell cycle activity and 
cell proliferation in AsPC-1 (Schnelldorfer et al., 2000). 
The other model that shows a relationship between 
glutathione and resistance to chemotherapy is about 
causing resistance to cisplatin drug in curing breast 
cancer. This drug as a potential, uses the cytotoxic factor 
which causes damage to DNA, cell cycle and apoptosis 
initiation eventually (Rudin et al., 2003). Approximately, 
increasing glutathione level relates to cisplatin’s 
resistance, but this relationship does not relate to the 
function of decreasing cisplatin inactivation. One hypo-
thesis says that the glutathione ability of cisplatin 
cytotoxic inhibitory relates to glutathione antioxidant 
characteristic and it affects apoptosis regulation. For 
investigation of this hypothesis in the lab, MCF-7 breast 
cancer cells were used. The result of this investigation 
showed that high expression of Bcl-2 in MCF-7 cells has 
a relation to the increase of cell glutathione, which result 
in an increasing resistance to cisplatin. In this assay, 
when MCF-7 cells were combined to BSO glutathione 
level, they reached a normal level and their resistance to 
the dependent cisplatin disappeared completely. These 
investigations show that resistance to dependent cisplatin 
drug and Bcl-2 in relation to glutathione production 
causes cell survival due to the relationship between 
glutathione and Bcl-2, although Bcl-2 can affect the 
antioxidant ways (Rudin et al., 2003).  
Anticancer drugs in leukemia are susceptible to 
chemical materials, and in tumors, they induced 
apoptosis. Lack of apoptosis ways may result in resis-
tance to chemotherapy drugs. Resistance to inducing 
apoptosis by CD95, or anticancer drugs, depend on 
intracellular reduced glutathione level which may have a 
role in different parts surfaces in both the death-inducing 
signaling complex (DISK) CD95 and mitochondrial. This 
formation DISC and caspase 8 activities in the DISC that 
has a main role in apoptosis activation is involved with 
the intracellular reduced glutathione level and ROS 
production. DISC CD-95 contains several proteins such 
as Fas- associated death domain (FADD) and caspases 
which contain residue cysteine that can be changed with 
GSH. CD95 molecule acts as a receptor of TNF/NGF 
(Tumor necrosis factor/nerve growth factor) and mediates 
apoptosis according to oligomerization. Caspases activity 
as an important molecule induced death that may be 
initiated by at least two different promoters (dis-
appearance of the receptor or mitochondrial ways). 
Defect in these ways may result in resistance to 
apoptosis. For investigation of the cell resistance 
mechanism in apoptosis way, CEM cells (a kind of  T  cell  




leukemia resistance to CD95) are exposed to sequential 
treatment with anti APO-1 (anti CD95) that are adapted to 
the increase of CD95 resistance in these cells. As a 
consequence, they gradually develop resistance drugs 
and indicate defects in apoptosis way. GSH in apoptosis 
inducing regulation links CD95 with anticancer drugs in 
resistance cells to chemotherapy and resistance cells to 
anti cancer drugs. In fact, at the same time, the 
development of the CD95 resistance and the resistance 
to the anticancer drugs of the cellular GSH in resistance 
cell in comparison to innate cell is increased. Intracellular 
reduced glutathione down regulation with BSO result in 
CD95 induced apoptosis. Also, the mitochondrial is 
activated by caspases activation (down regulation 
mitochondrial membrane causes ROS production, and 
the mitochondrial acts as a promoter for the activation of 
caspase 3, 8), while it is basically lacked in apoptosis 
ways and it disappears by anticancer drugs or CD95 (48). 
On the other hand, the glutathione system, pertaining 
enzymes, also changes under investigation in many 
cancers. Their results increased glutathione S- trans-
ferase in patients that are affected by esophagitis and 
esogastritis in comparison to people who are under 
controlled serum, and also increased the level of this 
enzyme in 60 to 80% patients due to the fact that the 




GLUTATHIONE AND CELL PROLIFERATION 
 
The other role for glutathione is about the effect it has on 
cells proliferation process. Different studies indicate that 
glutathione involves different cells proliferation such as 
human fibroblast cells, lymphocyte, hepatocytes, mouse 
bone marrow cells and intestinal epithelial cells (Kirlin  et 
al., 1999; Chatterjee et al., 1995).  
Reduced glutathione (GSH) is a major low molecular 
weight thiol in cells and plays a central role in controlling 
cellular thiol/disulfide redox state, which is essential for 
normal redox signaling. Calculation of GSH/oxidized 
glutathione (GSSG) values in proliferating cells suggest 
that as cells progress from proliferation through contact 
inhibition, differentiation and finally apoptosis, there is a 
natural progression from a more reduced to a more 
oxidized (Ahmadi Ashtiani et al 2011). Glutathione can 
affect cell proliferation from different ways. Glutathione as 
an intracellular antioxidant has a key role in factors 
activation regulation such as JNK and P38- MAPK
 
and 
this role has direct relation with intracellular reduced 
glutathione concentration. When the intracellular gluta-
thione concentration increases, activation of P38MAPK 
and JNK can be inhibited (Cuadrado et al., 2003). 
Glutathione act as an inhibitor by alkyl agents such as 
methyl methanesulfonate and N-methyl-N-nitro-N-
nithrosoguandine. By inhabitation, the activated JNk, 
P38MAPK and  Bcl-2  anti-apoptosis  result  in  apoptosis  




inhabitation and increased proliferation as well (Cuadrado 
et al., 2003). 
The relationship between the reduced glutathione and 
ROS is one of the other effective agents on cell prolife-
ration. ROS, especially hydrogen peroxide and super-
oxide, plays a key role in cellular death and proliferation. 
This compound usually stimulate cellular growth in 
submicromolar concentration, while in high concentration 
(more than 10 to 30 micromolar), it can result in necrosis 
cells and apoptosis (Day and Suzuki, 2005). In fact, the 
high concentration of this compound causes the 
activation of the transcription factors such as MAPK and 
NF-кB, following the cellular death that occurs, whereas 
in low concentration, it causes an activation of other 
transcription factors such as ARE (for example Nrf2). 
ARE transcription factor has a role in enzyme γ-GCS 
gene expression regulation. This enzyme is a key 
enzyme for the control of glutathione synthesis and is 
produced in response to xenobiotic. The result of this 
activation occurs after cellular proliferation, due to the 
increase of the reduced glutathione concentration. The 
following figure indicates that as long as ROS is 
produced in high concentration, cellular death occurs and 
when ROS is produced in low concentration, glutathione 
is synthesized and the cellular proliferation occurs (Day 
and Suzuki, 2005). 
Glutathione can also affect tumor necrosis factor-α 
(TNF-α). TNF-α is a cytokine that is derived from micro-
phage – monocyte cells that have a key role in infection 
and immunology. Cytokine TNF-α plays a lot of roles in 
biology such as antitumor and cellular proliferation 
inhibitor. The reactive oxygen intermediate (ROI) 
molecules stimulate the ability of cell death TNF-α, while 
TNF-α by intermediation in the normal process of electron 
transfer in mitochondrial membrane produces ROI which 
involves dead cells and damage to DNA (Schnelldorfer et 
al., 2000). Resistance to TNF-α refers to antioxidant cells’ 
ability in tumor cells and also the high concentration of 
the reduced glutathione intracellular which is a resistance 
agent to TNF-α (Obrador et al., 1997). Also, resistance to 
TNF-α is influenced by the high glutathione level which 
prevents the death of cells and thus, maintains gluta-
thione (Obrador et al., 1997). In addition, the high 
concentration of the reduced glutathione intracellular, by 
other mechanisms, affects cell proliferation and stimu-
lates mitogenic ability in cells. Reduced glutathione has a 
role in DNA synthesis regulation. Also, glutathione with 
activity regulation of protein kinase C (PKC) and 
intracellular pH controls tumor proliferation (Obrador et 
al., 1997). Evacuation reduced glutathione in cancer cells 
with compounds such as BSO, which prevented them 
from activating the protein kinase C (PKC) and which 
decreased the intracellular pH (Terradez et al., 1993). 
Glutathione plays a key role as a regulator in T lympho-
cytes proliferation. In the study where T lymphocytes 
were performed after using BSO inhibitor, glutathione 





controlled (Friesen et al., 2004). The investigation 
indicated that a decrease of the reduced glutathione 
concentration prevented the lymphocytes development 
from phase G1 to phase S cell cycle. However, the 
agents that increased the cellular reduced glutathione, 
increased the proliferation of lymphocytes in response to 
interleukin-2, while they prevented the reduced gluta-
thione synthesis interleukin-2 level. In another study, the 
reduced glutathione impression on HT-29 cells derived a 
human colon carcinoma cell that has been investigated 
and which affected the sodium butyrate of this cell. This 
material caused a decrease in the reduced glutathione 
and finally in the cellular proliferation (Kirlin et al., 1999). 
In other study, it was indicated that when the treatment of 
CaCO2 cells with BSO cellular glutathione level 
decreased alone, there was no change in GSH (GSSG). 
However, in this case, there was a little effect on the 
cellular proliferation, but the treatment of cell with diamide 
and 1,3-bis (2 chloroethyl)-1 nitrosourea (BCNU) 
(inhibitor reductase glutathione enzyme activity) decree-
sed the GSH level and increased the GSSG level. 
Besides, the ratio of GSH: GSSG decreased. The 
decrease of the inhibitory effects, by N-acetylcysteine 
(NAC), on these changes is related to the decrease of the 
cellular proliferation. On the other hand, compounds such 
as BSO decreased the reduced glutathione level, but 
there was no change in GSH (GSSG ratio). In this 
survey, they concluded that although BSO has no effect 
on cellular proliferation, its presence can improve BCNU 
and diamide the inhibitory effect (Taahiro and Ryuich, 
2001). In other survey about glutathione effect on cellular 
proliferation, its role improves the intestinal cells 
proliferation. In this study, the role of glutathione on 
apoptosis or proliferation is investigated by NAC and 
BSO. Documents show that glutathione concentration 
balance is a key mechanism in intestinal cells prolife-
ration control (Buccigrossi et al., 2009).   
 
 
DIFFERENTIATION AND GLUTATHIONE 
 
Glutathione plays a major role in differentiation process, 
although studies indicate that glutathione plays a role in 
the cellular proliferation process. The finding of the study 
that was performed on the skeletal muscle cells of C2C12 
suggests that GSH level 24 h after cells stimulation to 
differentiation increased and later decreased. Sub-
sequently, after 5 days, it reached the first level which 
indicated that GSH has a stimulatory effect on cellular 
proliferation. Also, it was observed that by adding BSO 
and decreasing GSH during the first day, cells 
differentiation rate decreased in the third day and this 
decrease continued until the seventh day. In addition, 
with the increasing of GSH, the skeletal muscle 
differentiation cells increased as well. Skeletal muscle 
differentiation is a complex process whose regulation 





24 h after the myoblast stimulation, increased because of 
stimulation of L-cysteine ligase glutamate activity. 
Glutathione involves the formation of myotube from 
satellite myoblast by activation of nuclear factor kappa B 
(NF-KB). However, a recovery of the optimal glutathione 
level in muscle mass differentiation in chronic inflame-
mation has been useful (Ardite et al., 2004). In other 
study that was performed on the mouse fibroblast cells, 
the researcher concluded that while cells division (6 to 24 
h after culture) percent of Bcl-2 was very high, this 
amount was decreased after this time (48 h to 5 days 
after culture) and at the same time that a decrease in the 
cellular growth occurred. Nevertheless, glutathione in 
fibroblast 3T3 occurred before cellular growth increased. 
High level of telomerase activity was followed 24 h after 
the culture occurred and at the same time that the 
maximum level of glutathione in cells happened. Also, 
telomerase activity was maximally seen than the 
reduction condition. After 24 h culture, 3T3 fibroblast 
initiated growth, while for 24 to 48 h, it increased 
incredibly after culture cells percents in S+G2/M. After 72 
h culture, cell growth decreased and after 6 days, most of 
the cells are in G0/G1. Glutathione concentration is found 
to be at its maximum in all cells after 24 h culture, when 
high percent cells are coming or preparing for division. 
While cell populations are in G0/G1 phase, glutathione is 
very low (Markovic et al., 2007). Thus, glutathione 
nuclear distribution has a main role in cell cycle deve-
lopment during the first phase of the cellular culture, and 
when cells initiated growth, glutathione can be replaced 
in the nuclear cell (Markovic et al., 2007; Mihm et al., 
1995).  
Studies indicate that the mouse bone marrow stromal 
cells (BMSCs) can be differentiated from the neuron cells 
by adding 2- mercaptoethanol. When the bone marrow 
stromal cells are found with a little glutathione passage 
differentiation, the neuron cells occur, but using 
glutathione monoethyl ester (GEE) to increase the 
intracellular reduced glutathione concentration, there has 
been no effect on the neuron marker expression, so it 
can be said that the extracellular reduced glutathione is 
very effective on the stromal stem cell differentiation to 
neuron cells, but the intracellular reduced glutathione has 
no any effect on this trend (Sagara and Makino, 2008). In 
other study that was performed on the mouse 
preadipocyt cells differentiation to adipocytes, it was 
concluded that the presence of ROS can accelerate 
adipocyte differentiation, while when the reduced 
glutathione presents its ROS level; it also decreased 
following the decrease of adipocyte differentiation. Thus, 
it is concluded that GSH has an effective compound in 
decreasing adipocyte number (Toshiyuki and Takahito, 
2009). In another study, Kim et al. looked for the 
relationship between GSH and macrophage differen-
tiation derived from the bone marrow monocyte and their 
phagocyte activation. They indicated that: (1) GSH/GSSG 
ratio   during  bone  marrow  monocyte  (BMMs)  differen- 




tiation to macrophage cells decreased. BMMs were taken 
from Tibia mouse and were exposed with M-CSF diffe-
rentiation to macrophage. (2) A decrease of the GSH 
level is prevented from the macrophage differentiation. 
(3) Inhibitory effects of GSH depletion on differentiation 
are performed by C-fms gene down expression 
regulation. (4) GSH can regulate phagocyte activity in 
relation to macrophage (Jin-Man and Hyunsoo, 2004). To 
evaluate this, a study about the presence of glutathione 
system evacuation (BSO) and glutathione system 
supporter (NAC) was done. Moreover, the investigation of 
the cells position by these compounds suggests a 
conclusion of the level of GSH. With the presence of 
BSO, preventing the composition of the macrophage 
occurs with a down regulation of C-fms gene, but it does 
not have any effect on the phagocytic activity since the 
macrophage phagocytic activity relates to the increase of 
the ROS level, and when the cellular GSH level is low, 
more levels of ROS in the cells occur. While saturation of 
cells by N-acetyl cysteine does not have any effect on 
macrophage differentiation, the phagocytic activity 
decreased because the saturation of cells with GSH 
position of reduced redox in cell increases, thereby 
decreasing the phagocytic activation of macrophage. M-
CFS as one of the growth factors is necessary for BMMs 
development, while contamination between M-CFS and 
the acceptor (which stimulates the macrophage differen-
tiation), as a set of development reactions, mediate 
macrophage. M-CSF linkage with its receptor causes 
spontaneous phosphorylation tyrosine kinase following 
the fact that cellular signals are increased for 
proliferation, differentiation and survival. M-CSF stimulate 
C-fms gene expression by linkage of several transcription 
factors to C-fms gene promoter. However, in a perfor-
mance of the down regulation from C-fms gene, the GSH 
level decreased and resulted in a dependent differen-
tiation decrease of M-CSF (Jin-Man and Hyunsoo, 2004). 
Allameh et al. (2009) investigated the hepatocytes 
differentiation trend from mesenchymal cells. It was 
concluded that the derived bone marrow of the cellular 
GSH level decreased (20%≈) in the differentiated 
hepatocytes from mesenchymal cells in comparison to 
the control group, which implied that the differentiation 
hepatogenic of the MSC was derived from the human 
bone marrow with involved factors regulation in GSH 
conjugation ways (Allameh et al., 2009). 
 
 
FETUS AND GLUTATHIONE  
 
Increasing the intracellular ROS causes thermal shock 
delays in the development of the fetus or fetus death. 
Reports indicate that the thermal shock defects the fetus 
mitochondrial function and morphology. Although the 
BSO decreases fetus development, high level of 
glutathione is necessary for the cleavage of the ROS 
witch  to  be  produced  by  thermal  shock.  In  fact, mito- 




chondrial glutathione maintains cell vitality by ROS 
elimination (Miki et al., 2008). β- Mercaptoethanol can 
decrease the produced ROS witch, which directly causes 
an increase in the glutathione level. The fetus witch that 
is exposed to thermal shock, without mercaptoethanol, 
has high level of ROS and it decreased fetuses’ 
development in comparison to the fetus witch that is not 
exposed to thermal shock. β- Mercaptoethanol is a 
reduced agent and acts as an antioxidant which 
disappear from hydroxyl radical with (sulfhydryl) the SH 
group. Indication of this compound stimulates glutathione 
synthesis and also induces thiol that stimulates cystine 
reduced reaction to cysteine, and finally results to the 
synthesis of glutathione (Miki et al., 2008). GSH has a 
main role in growth, development and fetus organization. 
In fact, this compound decreases the intracellular ROS 
level that has the ability to destroy the effect of the fetus 
formation and helps in fetus formation. In the study that 
was done on the regulation of diabetic and normal mice, 
it was concluded that hyperglycemia resulted in a dis-
ruption of the organization by causing free radicals and 
intracellular GSH depletion in fetus tissues. Intracellular 
GSH in the fetus tissue of diabetic pregnant mice in 
comparison to normal mice is low and also the enzyme 
level witch synthesis GSH in diabetic mice fetus is low 
because of the decrease that relates to the mRNA 
expression of this enzyme in this mouse. BSO is a 
special inhibitor of GSH synthesis which decreases 
intracellular GSH level and causes nervous damages, 
while GSH esters in diabetic mice maintain GSH in fetus 
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